2026 DHLRI Research Day
2026 DHLRI Research Day
Thursday, October 8, 2026
The 2026 DHLRI Research Day will be held on Thursday, October 8 from 9:00am - 3:30pm. The day's activities will begin on the 1st floor of the Biomedical Research Tower (BRT) with poster presentations, short talks, and lunch, followed by the keynote lecture in DHLRI 170.
Keynote Speaker
This year's keynote speaker is Calum MacRae, MD, PhD. More information on our speakers for the event can be found below.
Abstract Submissions
Abstract submissions and registration are now closed.
Questions?
If you have any questions, please reach out to Izabelle.Lange@osumc.edu.
-
8:30am Poster Set-Up
BRT Lobby
9:00am - 11:0am Poster Session
BRT Lobby
11:00am Opening Remarks | Thomas Hund, PhD - Director, DHLRI
BRT 115
11:00am - 12:00pm Short Talks
BRT 115
Short Talks Speakers To Be Announced
12:00pm - 1:00pm Lunch 1:20pm Introduction to Keynote Speaker | John Warner, MD - CEO, Wexner Medical Center
DHLRI 170
1:30pm Keynote Lecture | Calum MacRae, MD, PhD
"Closing the loop - strategies for integrating fundamental science, translation and care”
DHLRI 170
2:15pm Keynote Q&A
DHLRI 170
2:45pm Awards Opening Remarks | Amy Moore, MD - Interim Dean, College of Medicine
DHLRI 170
2:50pm Awards
DHLRI 170
-
DHLRI Research Day Program Booklet View the 2026 DHLRI Research Day Book Here
-
2026 DHLRI Research Day Keynote Speaker
Calum MacRae, MD, PhD
Director, One Brave Idea
PI, Apple Health Study
Professor of Medicine, Harvard Medical SchoolCalum A. MacRae, MD, PhD, is a Professor of Medicine at Harvard Medical School, the Director of One Brave Idea (a biomedical innovation program founded by Verily, the American Heart Association and AstraZeneca), Vice Chair for Scientific Innovation in the Department of Medicine at Brigham and Women’s Hospital in Boston, a Principal Faculty Member at the Harvard Stem Cell Institute, and an Associate Member at the Broad Institute of Harvard and MIT. He directs an NIH-funded basic science group and has developed systematic approaches at the tech::bio interface to uncover novel human disease mechanisms. He is the principal investigator of the Apple Health Study and works on the integration of digital health and genomics with multiple large technology companies. In his clinical work, he is a Cardiologist and Geneticist, co-directs the Genomic Medicine Program at Brigham and Women’s Hospital and is a clinical lead in the Harvard Undiagnosed Diseases Center. He and his collaborators have created rigorous approaches to automating accessible components of biomedicine to enable transformation of care delivery and real-world discovery, while building a foundation for continuously learning biomedical systems.
2026 DHLRI Short Talks Speakers
To Be Announced
-